Patent · US Expired

Use of cortisol antagonists in the treatment of heart failure

US6881739B1 · kind B1 · utility

1Cited by

6References

13Claims

0Family size

Inventors

Per Marin · Mölndal, SE
Sten Sorensen · Skanör med Falsterbo, SE

Key dates

Filing date	Jul 3, 2000
Grant date	Apr 19, 2005
Priority date	—
Expiry date	Jul 3, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P11/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of a cortisol antagonist in the manufacture of a medicament for the treatment of heart failure as well as to a method of treating heart failure which comprises administration of a cortisol antagonist and to a product containing (a) a cortisol antagonist and (b) a second drug as a combined preparation for simultaneous, separate or sequential use in the treatment of heart failure or in improving cardiac function and reducing exercise intolerance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.